Wall Street Analysts Are Bullish on Top Healthcare Picks
Wall Street analysts are showing bullish sentiment towards the healthcare sector, specifically highlighting Community Health (CYH) and Perspective Therapeutics (CATX). Analysts from RBC Capital have maintained Buy ratings on both stocks, with price targets indicating potential upside. Community Health has a consensus Hold rating, while Perspective Therapeutics holds a Strong Buy consensus.
RBC Cites Stable Business Model For Concentra Group Holdings Parent, Inc. (CON) Amid Macroeconomic Volatility
RBC Capital has raised its price target for Concentra Group Holdings Parent, Inc. (CON) to $31 from $30, maintaining an Outperform rating due to the company's stable business model despite macroeconomic volatility and strong Q4 performance. The company, a leading U.S. occupational health services provider, anticipates FY2026 revenue between $2.25 billion and $2.35 billion and is expanding with a new medical center in Georgia. RBC highlighted CON's Q4 pre-announcement as above consensus and its early projection for FY2026.
Concentra Group Holdings (CON): Analyst Ratings Signal 21% Upside In Healthcare Stock
Concentra Group Holdings (CON) is presented as an attractive investment in the healthcare sector, particularly for occupational health services. The company shows strong financial performance with high revenue growth and return on equity, and a sustainable dividend policy. Positive analyst sentiment indicates a potential upside of over 21% for the stock.
Concentra Group Holdings Parent, Inc. (NYSE:CON) Receives Consensus Rating of "Moderate Buy" from Brokerages
Concentra Group Holdings Parent, Inc. (NYSE:CON) has received a consensus "Moderate Buy" rating from five analysts, with an average 12-month price target of $29.00. Recent upgrades include RBC boosting its target to $31.00, and institutional investors like Barrow Hanley and Woodline Partners have significantly increased their stakes. The company, which specializes in financial services for Canadian credit unions, currently trades at $23.17 with a market capitalization of $2.97 billion.
Concentra Group stock hits 52-week high at 24.05 USD By Investing.com
Concentra Group Holdings Parent Inc.'s stock reached a new 52-week high of $24.05, representing a 6.62% increase over the past year, indicating strong investor confidence and market position. The company also reported exceeding its 2025 financial guidance with $2.16 billion in revenue and $431.9 million in adjusted EBITDA, alongside expanding its occupational health center footprint into Tucker, Georgia, and Hialeah, Florida. These developments highlight the company's growth and expansion in the occupational health services sector.
Concentra Group stock hits 52-week high at 24.05 USD
Concentra Group Holdings Parent Inc.'s stock reached a 52-week high of 24.05 USD, reflecting a 6.62% increase over the past year and indicating strong investor confidence. This milestone follows the company exceeding its 2025 financial guidance with $2.16 billion in revenue and expanding its operational footprint with new occupational health centers in Georgia and Florida. These developments highlight Concentra's growth trajectory and expanding presence in the occupational health services sector.
Concentra Group Holdings Parent (NYSE:CON) Sets New 12-Month High - What's Next?
Concentra Group Holdings Parent (NYSE:CON) reached a new 52-week high of $24.26, closing at $24.13 on robust trading volume. Analyst sentiment is generally positive, with a "Moderate Buy" consensus and a target price of $29.00, supported by recent upgrades and an increased price target from RBC. Institutional investment has also surged, notably with a significant new stake from Norges Bank and increased holdings by other major investors.
Concentra Group stock hits 52-week high at 24.05 USD By Investing.com
Concentra Group's stock reached a new 52-week high of $24.05, reflecting a 6.62% increase over the past year and indicating strong investor confidence. This performance follows the company's report of exceeding its full-year 2025 guidance with $2.16 billion in revenue and $431.9 million in adjusted EBITDA, alongside the expansion of its occupational health services with new centers in Georgia and Florida.
Concentra Group Holdings (CON): Analyzing A 23% Upside Potential In Healthcare
Concentra Group Holdings (CON) is presented as a strong player in the healthcare sector, specifically in occupational health services, with a market capitalization of $2.97 billion. The company shows robust financial health, including substantial revenue growth, high return on equity, and efficient management, indicated by a forward P/E ratio of 15.73 and strong cash flow. Analysts are highly positive, with all 7 ratings being "buy" and an average target price suggesting a 23.47% upside potential, making it an attractive investment for growth-focused investors.
Concentra Group Holdings Parent (CON) Is Up 8.9% After 2026 Guidance And Completed Share Buyback – What's Changed
Concentra Group Holdings Parent (CON) saw its shares rise 8.9% following the release of its 2026 guidance, which forecasts revenue between US$2.25–US$2.35 billion and net income of US$182–US$197 million. The company also completed a US$22.4 million share repurchase and opened a new occupational health center, signaling a focus on both operational growth and capital return. While these updates sharpen earnings expectations and tighten share count, the article notes existing risks such as high leverage and board structure.
Concentra Group Holdings Parent (NYSE:CON) Price Target Raised to $31.00 at Royal Bank Of Canada
Royal Bank of Canada has raised its price target for Concentra Group Holdings Parent (NYSE:CON) to $31.00 from $30.00, maintaining an "outperform" rating. This new target suggests a potential upside of approximately 39.89% from the stock's previous close. The company recently reported strong earnings, beating EPS expectations and showing a 17% year-over-year revenue increase.
Thrivent Financial for Lutherans Has $67.93 Million Holdings in Concentra Group Holdings Parent, Inc. $CON
Thrivent Financial for Lutherans significantly increased its stake in Concentra Group Holdings Parent, Inc. (NYSE:CON) by 41.1% in Q3, now holding 3,245,778 shares valued at approximately $67.93 million. This represents about 2.53% of the company. Concentra recently outperformed Q3 earnings expectations, reporting an EPS of $0.39 and revenue of $572.8 million, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $28.00.
RBC Lifts Price Target on Concentra Group Holdings Parent to $31 From $30, Keeps Outperform Rating
RBC has increased its price target for Concentra Group Holdings Parent (CON) to $31 from $30, while maintaining an Outperform rating. This update comes as Concentra announced its preliminary 2025 financial results and provided earnings guidance for 2026, alongside news of expanding its medical centers and appointing a new chief data officer.
Concentra releases preliminary 2025 results, provides 2026 guidance
The article from MSN states that Concentra has released its preliminary financial results for the year 2025. Additionally, the company has provided guidance for its financial expectations for the upcoming year 2026.
Should Stronger‑Than‑Guided 2025 Results and New 2026 Outlook Require Action From Concentra (CON) Investors?
Concentra Group Holdings Parent, Inc. (CON) recently reported 2025 preliminary results that surpassed guidance and issued a new 2026 revenue outlook of US$2.25 billion to US$2.35 billion. The company also completed a US$22.4 million share repurchase and expanded its network with a new occupational health center. These developments reinforce Concentra's investment narrative as a focused occupational health platform, though risks like debt, profit margins, and board inexperience remain.
Should Stronger‑Than‑Guided 2025 Results and New 2026 Outlook Require Action From Concentra (CON) Investors?
Concentra Group Holdings Parent, Inc. recently exceeded its 2025 guidance and issued a positive 2026 revenue outlook, along with a share repurchase and new clinic opening. While these actions reinforce the company's investment narrative of a focused occupational health platform with steady cash generation, key risks remain, including high debt and softer profit margins. Investors should consider these factors and multiple fair value estimates before making investment decisions.
Analysts Are Bullish on Top Healthcare Stocks: Concentra Group Holdings Parent, Inc. (CON), Neurocrine (NBIX)
Two healthcare stocks, Concentra Group Holdings Parent, Inc. (CON) and Neurocrine (NBIX), have received bullish sentiments from analysts. Bank of America Securities reiterated a Buy rating on CON with a $27.00 price target, while Citi maintained a Buy rating on NBIX with a $203.00 price target. Both companies are seen to have significant upside potential according to analyst consensus.
Should Stronger‑Than‑Guided 2025 Results and New 2026 Outlook Require Action From Concentra (CON) Investors?
Concentra Group Holdings Parent, Inc. recently exceeded its 2025 guidance and issued a new 2026 revenue outlook of US$2.25 billion to US$2.35 billion, alongside a US$22.4 million share repurchase and the opening of a new occupational health center. These developments reinforce the company's investment narrative of a focused occupational health platform with steady cash generation, despite risks like heavy debt and softer profit margins. While the shares might still be trading above fair value, these actions offer investors a clearer view of management's confidence and operational scale.
Concentra Announces Preliminary 2025 Financial Results, Provides 2026 Financial Guidance, and Announces Q4 2025 Earnings Call Date
Concentra Group Holdings Parent, Inc. (NYSE: CON) released preliminary unaudited financial results for Q4 and full year 2025, exceeding previous guidance, and provided its preliminary 2026 business outlook. The company reported significant revenue and Adjusted EBITDA growth for 2025, driven by an increased number of locations and patient visits. Concentra also announced its Q4 and full year 2025 earnings call on February 27, 2026, and published an Investor Book detailing its business and industry.
New Tucker clinic offers work injury care, drug tests, telemedicine
Concentra, a leader in occupational medicine, has opened a new medical center in Tucker, Georgia, expanding its presence in the region. The new facility will offer comprehensive occupational health services including work injury care, physical therapy, drug testing, and telemedicine for minor injuries. This expansion aims to enhance access to quality healthcare for employers and workers in DeKalb County.
Concentra Expands to Tucker, Georgia
Concentra, a national leader in occupational medicine, has opened a new medical center in Tucker, Georgia, located at 4434 Hugh Howell Road. This expansion aims to provide comprehensive occupational health services, including work injury care, physical therapy, and drug testing, to employers and workers in DeKalb County. The new facility will also offer telemedicine services through Concentra Telemed®, further strengthening Concentra's presence in Georgia.
Concentra Group Holdings Parent (NYSE:CON) Hasn't Managed To Accelerate Its Returns
Concentra Group Holdings Parent (NYSE: CON) shows decent returns on capital employed (ROCE) at 13%, which is close to the healthcare industry average. The company has maintained this ROCE while reinvesting 24% more capital into its operations over the past two years. While these consistent returns are positive, the stock has not delivered significant growth in total shareholder returns recently, suggesting investors might need to look deeper into its fundamentals.
Massachusetts Financial Services Co. MA Trims Stake in Concentra Group Holdings Parent, Inc. $CON
Massachusetts Financial Services Co. MA reduced its stake in Concentra Group Holdings Parent, Inc. (NYSE:CON) by 2.6% in Q3, selling 50,201 shares. Despite this, other institutions like State Street, JPMorgan Chase & Co., and Geode Capital Management LLC increased their holdings, and Norges Bank initiated a new position. Concentra Group Holdings Parent has a "Moderate Buy" consensus rating from analysts, a $2.82 billion market cap, and recently surpassed quarterly earnings estimates.
Concentra Acquires Reliant Immediate Care from MBI Industrial Medicine
Concentra, a leader in occupational medicine, has acquired the assets of Reliant Immediate Care from MBI Industrial Medicine in California, expanding its presence in the greater Los Angeles area. This acquisition converts three Reliant clinics into Concentra centers, while one will merge with an existing Concentra location. The new centers will offer a range of occupational health services, including work injury care, urgent care, physical therapy, and drug testing.
Is Concentra (CON) Using Inflation-Linked Pricing to Quietly Redefine Its Occupational Health Profit Engine?
Concentra Group Holdings Parent, Inc. (CON) presented at the J.P. Morgan Healthcare Conference, emphasizing its leading role in occupational health and reliance on non-GAAP metrics like Adjusted EBITDA and ROIC. The company's focus on inflation-linked fee-for-service pricing and a consistent quarterly dividend suggests a strategy to balance growth, debt reduction, and shareholder returns amidst high leverage and cost pressures. While the company projects significant revenue and earnings growth by 2028, investor perspectives vary, highlighting the importance of considering multiple viewpoints and the company's financial health before making investment decisions.
Is Concentra (CON) Using Inflation-Linked Pricing to Quietly Redefine Its Occupational Health Profit Engine?
Concentra Group Holdings Parent, Inc. (CON) presented its financial framework at a J.P. Morgan conference, highlighting its role as a leading U.S. occupational health provider and its reliance on non-GAAP metrics. The company's investment narrative emphasizes scale, fee-for-service pricing, and inflation-linked pricing, alongside a regular dividend, to balance growth, debt reduction, and shareholder returns. While projecting significant revenue and earnings growth by 2028 and a fair value suggesting a 31% upside, investors are urged to consider its high debt load and compare multiple viewpoints.
Is Concentra (CON) Using Inflation-Linked Pricing to Quietly Redefine Its Occupational Health Profit Engine?
Concentra Group Holdings Parent, Inc. (CON) recently presented at the J.P. Morgan Healthcare Conference, emphasizing its role as a leading occupational health provider and its reliance on non-GAAP metrics like Adjusted EBITDA. The company highlighted its strategy of inflation-linked fee-for-service pricing, consistent dividends, and focus on free cash flow, aiming to balance growth and debt reduction. Investors should consider the company's high leverage alongside its projected revenue and earnings growth.
Concentra Group Holdings Parent, Inc. (NYSE:CON) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Concentra Group Holdings Parent, Inc. (NYSE:CON) has received a "Moderate Buy" consensus recommendation from six brokerages, with an average one-year target price of $27.75, significantly higher than its recent share price of $21.46. The company recently surpassed its quarterly earnings and revenue estimates, reporting $0.39 EPS and $572.8 million in revenue. Institutional investors have also been actively increasing their stakes in CON, indicating confidence in its financial performance and future prospects.
CON: Industry leader with resilient growth, strong margins, and flexible capital deployment
Concentra Group Holdings Parent, Inc. (CON) showcased its leadership in occupational health, detailing robust growth via organic expansion and M&A, alongside strong financial performance marked by high margins and cash flow. Management highlighted resilience in challenging labor markets, consistent rate increases, and a adaptable capital allocation strategy. This summary is based on the company's 44th Annual J.P. Morgan Healthcare Conference Audio Transcript from January 14, 2026.
Concentra Group Holdings: Resilient Growth, Strengthening Fundamentals, and Attractive Valuation Support Buy Rating
Bank of America Securities analyst Joanna Gajuk maintained a Buy rating on Concentra Group Holdings Parent, Inc., with a price target of $27.00. This rating is based on the company's resilient growth, stronger-than-expected fourth-quarter visit volumes, and reaffirmation of 2025 guidance. Gajuk also noted the company's prudent balance sheet management, strong free cash flow, and attractive valuation.
Tributary Capital Management LLC Buys Shares of 1,008,532 Concentra Group Holdings Parent, Inc. $CON
Tributary Capital Management LLC recently acquired 1,008,532 shares of Concentra Group Holdings Parent, Inc. (NYSE: CON) for approximately $21.1 million, establishing a new position representing 0.79% of the company. Other major institutions like State Street, JPMorgan, and Geode also increased their stakes, signaling growing institutional interest. Concentra Group Holdings Parent, a Canada-based financial services holding company for credit unions, has a market capitalization of $2.50 billion and recently declared a quarterly dividend of $0.0625.
The Returns At Concentra Group Holdings Parent (NYSE:CON) Aren't Growing
Concentra Group Holdings Parent (NYSE:CON) shows a decent but stable Return on Capital Employed (ROCE) of 13%, which is close to the healthcare industry average. While the company has reinvested capital to expand its operations by 24% over the last two years, the ROCE has remained consistent, indicating that returns haven't been growing. Despite this, the ability to maintain good rates of return suggests a stable business, and the article recommends further investigation given the stock's modest 0.2% rise over the past year.
Wall Street Zen Upgrades Concentra Group Holdings Parent (NYSE:CON) to "Buy"
Wall Street Zen has upgraded Concentra Group Holdings Parent (NYSE:CON) from "hold" to "buy," contributing to a consensus "Moderate Buy" rating with an average price target of $27.75. The company recently reported $0.37 EPS and $489.6 million in quarterly revenue, trading with a market capitalization of $2.57 billion and a P/E of 16.73. Institutional investors like American Century and Raymond James have increased their stakes, indicating positive sentiment and recent inflows.
Concentra Group Holdings Parent (NYSE:CON) Upgraded by Zacks Research to Hold Rating
Zacks Research has upgraded Concentra Group Holdings Parent (NYSE:CON) from a "strong sell" to a "hold" rating. This upgrade aligns with other positive analyst views, including JPMorgan's "overweight" rating and a consensus "Moderate Buy" rating with an average $27.75 target price. The article highlights recent institutional investment, solid Q3 financial results with $0.37 EPS on $489.64 million revenue, and a 48.42% ROE.
Concentra Group Holdings Parent, Inc. (NYSE:CON) Given Consensus Rating of "Moderate Buy" by Analysts
Concentra Group Holdings Parent, Inc. (NYSE:CON) has received a "Moderate Buy" consensus rating from six analysts, with an average 12-month price target of $27.75. The company recently reported quarterly EPS of $0.37 on $489.6 million in revenue, an ROE of 48.42%, and pays a quarterly dividend of $0.0625. Institutional investors like Barrow Hanley and Woodline Partners have shown significant interest, increasing their stakes in the company.
Is Concentra Group Holdings Parent, Inc.'s (NYSE:CON) 39% ROE Better Than Average?
This article examines Concentra Group Holdings Parent, Inc.'s (NYSE:CON) Return on Equity (ROE) of 39%, comparing it to the Healthcare industry average of 15%. While the high ROE is positive, the analysis reveals that it is significantly boosted by the company's high debt-to-equity ratio of 3.94, suggesting the profitability might be less efficient without substantial leverage. Investors are advised to consider debt levels and other financial factors when evaluating the stock.
Thrivent Financial for Lutherans Decreases Position in Concentra Group Holdings Parent, Inc. $CON
Thrivent Financial for Lutherans has reduced its stake in Concentra Group Holdings Parent, Inc. by 8.4% in the second quarter, selling 210,449 shares. Despite this, they still own 2,300,475 shares valued at approximately $47.32 million. Concentra Group Holdings Parent (NYSE:CON) reported $0.37 EPS and quarterly revenue of $489.64 million, with the stock trading near $19.89 and analysts maintaining a "Moderate Buy" consensus.
Concentra Adds New Medical Center in Hialeah, Florida
Concentra, a leader in occupational medicine, has opened a new medical center in Hialeah, Florida, located at 855 East 8th Avenue. This expansion aims to serve more employers and enhance access to occupational health services, including work injury care, physical therapy, and drug testing. The new center also offers telemedicine options through Concentra Telemed®.
Concentra (CON): Assessing Valuation After Strong Q3 Results, Buy Ratings, and New Clinic Expansion
Concentra Group Holdings Parent, Inc. (CON) recently opened a new occupational health center, expanding its network amidst strong Wall Street support and climbing revenues and profits. The stock, currently at $19.87, is considered undervalued with a fair value of $28.13, due to strategic acquisitions, clinic expansion, and investments in digital transformation. However, potential risks include persistent margin pressure from integration costs and high leverage.
Concentra (CON): Assessing Valuation After Strong Q3 Results, Buy Ratings, and New Clinic Expansion
Concentra (CON) recently opened a new occupational health center, expanding its clinic network, while its stock garners Wall Street support. Despite a period of weaker performance, the company is seeing momentum rebuild with climbing revenue and profits, suggesting it may be undervalued with an intrinsic discount and analyst targets significantly above the current price. Strategic acquisitions and de novo clinic expansion are contributing to increased national footprint and service capabilities, expecting to improve EBITDA margins and earnings.
Concentra (CON): Assessing Valuation After Strong Q3 Results, Buy Ratings, and New Clinic Expansion
Concentra Group Holdings Parent, Inc. (CON) has recently opened a new occupational health center, contributing to its expanding clinic network, and its stock is supported by Wall Street. Despite a modest year-to-date share price return, the company shows climbing revenue and profits, with analysts suggesting a significant intrinsic discount and higher targets. The stock appears potentially undervalued, driven by strategic acquisitions, de novo clinic expansion, and investments in digital transformation.
Camber Capital Management LP Decreases Stock Holdings in Concentra Group Holdings Parent, Inc. $CON
Camber Capital Management LP significantly reduced its stake in Concentra Group Holdings Parent, Inc. (NYSE:CON) by 75% in the second quarter, selling 1,200,000 shares and retaining 400,000 shares valued at approximately $8.23 million. Concentra trades near $19.89 with a market cap of $2.55 billion and a P/E ratio of 16.58, and it pays an annual dividend of $0.25 (1.3% yield). Analyst consensus is a "Moderate Buy" with an average target price of $27.75, despite mixed individual ratings.
Concentra Group Holdings Parent, Inc. (CON) Receives a Buy from Mizuho Securities
Mizuho Securities analyst Ann Hynes has reiterated a Buy rating for Concentra Group Holdings Parent, Inc. (CON), with the company's shares closing at $19.87. The general Street consensus also suggests a Strong Buy with an average price target of $29.25. This positive outlook follows Concentra's strong Q3 earnings, reporting a revenue of $572.8 million and a net profit of $48.26 million, showing significant growth from the previous year.
Is Concentra Group Holdings Parent (CON) Quietly Repositioning Around Telemed With Its New Corona Clinic?
Concentra Group Holdings Parent (CON) has opened a new occupational health medical center in Corona, California, integrating its Concentra Telemed platform. This expansion supports employer healthcare needs and deepens Concentra's California footprint, aligning with its strategy of steady demand for employer-focused health services despite modest visit growth and margin pressure. The company balances clinic expansion and telemedicine integration with managing high leverage and maintaining its quarterly dividends, projecting significant revenue and earnings by 2028.
162,235 Shares in Concentra Group Holdings Parent, Inc. $CON Acquired by Gabelli Funds LLC
Gabelli Funds LLC has recently acquired 162,235 shares of Concentra Group Holdings Parent, Inc. (NYSE:CON), valued at approximately $3.34 million, establishing a new position representing about 0.13% ownership. Analyst sentiment for CON is mixed but generally leans positive, with a "Moderate Buy" consensus rating and an average price target of $27.75, despite a recent downgrade from Zacks Research to "Strong Sell." Concentra Group Holdings Parent reported an EPS of $0.37 on $489.6 million revenue last quarter, maintains a market cap of $2.52 billion, a P/E ratio of 16.38, and offers a quarterly dividend of $0.0625.
The upside story behind Concentra Group Holdings Parent, Inc. (CON)
This article is unavailable as the content provided only states "MSN" and does not offer any substantive text for summarization or cleaning. To provide an accurate summary and cleaned content, the full article text is required.
The Upside Story Behind Concentra Group Holdings Parent, Inc. (CON)
Concentra Group Holdings Parent, Inc. (NYSE: CON) is highlighted as a promising healthcare stock for 2026, with all seven analysts covering it giving a "Buy" or equivalent rating. The company reported strong third-quarter results, including significant increases in revenue, net income, and adjusted EBITDA. Concentra operates in occupational health services, and analysts project a median price target of $29, implying substantial upside potential.
The Upside Story Behind Concentra Group Holdings Parent, Inc. (CON)
Concentra Group Holdings Parent, Inc. (NYSE: CON) is highlighted as a cheap healthcare stock with significant upside potential, based on analyst ratings and recent financial performance. The company reported strong third-quarter results with increased revenue, net income, and adjusted EBITDA, driven by visit and rate growth. Analysts have reaffirmed "Buy" ratings with a median price target of $29, suggesting a nearly 49% upside.
Concentra Expands to Corona, California
Concentra, a leader in occupational medicine, has opened a new medical center in Corona, California, located at 629 North Main Street, Unit C-3. This expansion aims to provide comprehensive occupational health services, including work injury care, physical therapy, and drug testing, to employers and employees in the region. Telemedicine for minor work injuries will also be available through Concentra Telemed®.
12 Cheap Healthcare Stocks to Buy Heading into 2026
This article is part of a list detailing cheap healthcare stocks to consider for investment heading into 2026. It highlights Concentra Group Holdings Parent, Inc. (NYSE:CON), discussing its financial performance, analyst ratings, and growth prospects. The company reported significant increases in revenue, net income, and adjusted EBITDA in its third quarter.
